I-Mab (IMAB) Stock Chart & Stock Price History → Incredible Opportunity to Retire FAST! (From Crypto 101 Media) (Ad) Free IMAB Stock Alerts $1.81 -0.01 (-0.44%) (As of 10:38 AM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media I-Mab Stock Price Performance5 Day Performance+2.95%1 Month Performance+0.11%3 Month Performance+1.23%6 Month Performance+14.68%Year-To-Date Performance-4.63%1 Year Performance-40.00% Receive IMAB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for I-Mab and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto 101 MediaIncredible Opportunity to Retire FAST!A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.Click here to get instant access to the guide IMAB Stock Chart for Wednesday, May, 8, 2024 IMAB Chart by TradingView I-Mab Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/07/2024$1.79$1.82+1.68%$1.90$1.78178,985 shs$147.20 million05/06/2024$1.76$1.79+1.70%$1.82$1.7669,774 shs$144.78 million05/03/2024$1.77$1.76-0.28%$1.83$1.76126,493 shs$142.03 million05/02/2024$1.77$1.77$1.79$1.7696,975 shs$142.44 million05/01/2024$1.77$1.77-0.28%$1.81$1.73119,766 shs$142.44 million04/30/2024$1.80$1.77-1.67%$1.81$1.76147,404 shs$142.84 million Get the Latest News and Ratings for IMAB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for I-Mab and its competitors with MarketBeat's FREE daily newsletter. 04/29/2024$1.80$1.80$1.84$1.80224,277 shs$145.26 million04/26/2024$1.81$1.80-0.55%$1.83$1.8088,595 shs$145.26 million04/25/2024$1.81$1.81$1.81$1.78283,717 shs$146.07 million04/24/2024$1.80$1.81+0.56%$1.82$1.80109,542 shs$146.07 million04/23/2024$1.80$1.80$1.83$1.80204,961 shs$145.26 million04/22/2024$1.80$1.80$1.81$1.79143,848 shs$145.26 million04/19/2024$1.80$1.80$1.85$1.79335,382 shs$145.26 million04/18/2024$1.81$1.80-0.55%$1.83$1.79137,472 shs$145.26 million04/17/2024$1.79$1.81+1.12%$1.86$1.79389,710 shs$146.07 million04/16/2024$1.80$1.79-0.56%$1.83$1.78235,410 shs$144.46 million04/15/2024$1.81$1.80-0.55%$1.83$1.79403,981 shs$145.26 million04/12/2024$1.81$1.81$1.83$1.78264,153 shs$146.07 million04/11/2024$1.82$1.81-0.55%$1.83$1.79124,164 shs$146.07 million04/10/2024$1.80$1.82+1.11%$1.83$1.78222,750 shs$146.87 million04/09/2024$1.81$1.80-0.55%$1.83$1.79130,497 shs$145.26 million04/08/2024$1.83$1.81-1.09%$1.87$1.79215,151 shs$146.07 million04/05/2024$1.80$1.83+1.67%$1.83$1.76225,897 shs$147.68 million04/04/2024$1.83$1.80-1.64%$1.87$1.79297,805 shs$145.26 million04/03/2024$1.82$1.83+0.55%$1.84$1.78185,207 shs$147.68 million04/02/2024$1.81$1.82+0.55%$1.85$1.76242,772 shs$146.87 million04/01/2024$1.86$1.81-2.69%$1.87$1.80158,747 shs$146.07 million03/29/2024$1.86$1.86$1.90$1.84193,671 shs$150.10 million03/28/2024$1.87$1.86-0.53%$1.90$1.84193,670 shs$150.10 million03/27/2024$1.84$1.87+1.63%$1.88$1.79486,976 shs$150.91 million03/26/2024$1.86$1.84-1.08%$1.97$1.84513,969 shs$148.49 million03/25/2024$1.87$1.86-0.53%$1.94$1.85212,087 shs$150.10 million03/22/2024$1.81$1.87+3.31%$1.90$1.78393,076 shs$150.91 million03/21/2024$1.90$1.81-4.74%$1.91$1.80332,849 shs$146.07 million03/20/2024$1.82$1.90+4.40%$1.90$1.77308,363 shs$153.33 million03/19/2024$1.81$1.82+0.55%$1.86$1.75214,223 shs$146.87 million03/18/2024$1.86$1.81-2.69%$1.85$1.73341,933 shs$146.07 million03/15/2024$1.80$1.86+3.33%$1.86$1.70380,011 shs$150.10 million03/14/2024$1.84$1.80-2.17%$1.82$1.77606,205 shs$145.26 million03/13/2024$1.83$1.84+0.55%$1.94$1.82300,655 shs$148.49 millionBREAKING – Pentagon to Spend $20 Billion on “Distributed AI” (Ad)BREAKING - Pentagon to Spend $20 Billion on "Distributed AI" The U.S. Space Force calls it a "game changer." And one tiny firm is poised to win the contract to build it.Discover the name and ticker of this $2 stock here >>>03/12/2024$1.81$1.83+1.10%$1.83$1.75252,485 shs$147.69 million03/11/2024$1.85$1.81-2.16%$1.94$1.81323,938 shs$146.07 million03/08/2024$1.72$1.85+7.56%$1.85$1.73492,969 shs$149.30 million03/07/2024$1.73$1.72-0.58%$1.77$1.66304,853 shs$138.80 million03/06/2024$1.69$1.73+2.37%$1.75$1.66180,978 shs$139.61 million03/05/2024$1.71$1.69-1.17%$1.75$1.63210,330 shs$136.38 million03/04/2024$1.79$1.71-4.47%$1.82$1.68398,235 shs$138.00 million03/01/2024$1.78$1.79+0.56%$1.88$1.77234,733 shs$144.45 million02/29/2024$1.85$1.78-3.78%$1.91$1.76205,554 shs$143.65 million02/28/2024$1.85$1.85$1.93$1.80413,863 shs$149.30 million02/27/2024$1.74$1.85+6.32%$1.90$1.75526,582 shs$149.30 million02/26/2024$1.64$1.74+6.10%$1.75$1.62575,221 shs$140.42 million02/23/2024$1.57$1.64+4.46%$1.66$1.51359,467 shs$132.35 million02/22/2024$1.60$1.57-1.88%$1.65$1.55307,228 shs$126.70 million02/21/2024$1.64$1.60-2.44%$1.70$1.59323,575 shs$129.12 million02/20/2024$1.71$1.64-4.09%$1.73$1.63317,581 shs$132.35 million02/19/2024$1.71$1.71$1.79$1.69297,700 shs$138.00 million02/16/2024$1.77$1.71-3.39%$1.78$1.69297,790 shs$141.28 million02/15/2024$1.69$1.77+4.73%$1.82$1.72432,136 shs$146.24 million02/14/2024$1.65$1.69+2.42%$1.76$1.65450,835 shs$139.63 million02/13/2024$1.80$1.65-8.33%$1.78$1.64639,429 shs$136.32 million02/12/2024$1.73$1.80+4.05%$1.82$1.70467,435 shs$142.94 million02/09/2024$1.79$1.73-3.35%$1.85$1.70604,556 shs$142.93 million02/08/2024$2.00$1.79-10.50%$1.95$1.761.77 million shs$147.90 million02/07/2024$2.01$2.00-0.50%$2.08$1.84922,400 shs$165.24 million Related Companies: InterCure Stock Price Chart Regulus Therapeutics Stock Price Chart CervoMed Stock Price Chart Incannex Healthcare Stock Price Chart Adicet Bio Stock Price Chart Repare Therapeutics Stock Price Chart DiaMedica Therapeutics Stock Price Chart Prelude Therapeutics Stock Price Chart PDS Biotechnology Stock Price Chart Sagimet Biosciences Stock Price Chart Receive IMAB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for I-Mab and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:IMAB) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorFidelity, Bezos, Goldman Bet Big on Tiny BiotechBehind the MarketsElon Musk Secret Crypto Plot ExposedCrypto 101 MediaAI “wealth window” is closing June 25thParadigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressGold Set to EXPLODE!Gold Safe ExchangeThe AI Stock that’s Disrupting Every IndustryStockEarningsThe #1 lithium battery stock to have on your radar in 2024!Smallcaps Daily Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding I-Mab Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.